Cedars-Sinai Creates AI Tool for Predicting Gene Expression Patterns

Researchers at Cedars-Sinai have unveiled an innovative tool named Path2Space, designed to forecast spatial gene expression in tumor biopsy samples. This announcement was made in a May 8 news release from Cedars-Sinai and reported by Newswise. The team developed Path2Space using training data from breast cancer cases, where both slide images and spatial sequencing data were accessible. They then validated its efficacy across three additional patient datasets, as highlighted in the coverage. For each sample, the researchers successfully predicted the spatial expression of nearly 5,000 genes, with their predictions aligning closely with measured expressions across different cohorts, according to Newswise. Notably, Cedars-Sinai indicated that the method generates predictions in a matter of minutes and is significantly more cost-effective than traditional spatial profiling techniques, which can take weeks and incur costs of thousands of dollars. Eytan Ruppin from Cedars-Sinai emphasized the need for clinical validation before the tool can be integrated into patient care.